Emily Glover Dr Kate Smith-Jackson Dr Vicky Brocklebank Dr Valerie Wilson Dr Patrick Walsh et al. | Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome | 2023 |
|
Dr Vicky Brocklebank Dr Patrick Walsh Dr Kate Smith-Jackson Dr Thomas Hallam Professor Kevin Marchbank et al. | Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study | 2023 |
|
Dr Ruth Richardson Dr Valerie Wilson Dr Michael Wright
| Further delineation of phenotypic spectrum of SCN2A-related disorder | 2022 |
|
Professor Kevin Marchbank Dr Isabel Pappworth Harriet Denton Kate Cooke Grant Richardson et al. | C3 Glomerulopathy and Related Disorders in Children. | 2021 |
|
Dr Valerie Wilson Professor Sir John Burn Dr Akhtar Husain Professor Neil Rajan
| Detection of genetic tumour predisposition syndromes using electronic health records | 2020 |
|
Dr Vicky Brocklebank Dr Kate Smith-Jackson Dr Patrick Walsh Professor Kevin Marchbank Professor Claire Harris et al. | Long-term outcomes and response to treatment in DGKE nephropathy | 2020 |
|
Dr Majid Arefi Dr Valerie Wilson Dr Siobhan Muthiah Dr Simon Zwolinski Dr Dalvir Bajwa et al. | Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission | 2019 |
|
Professor David Kavanagh Dr Valerie Wilson Professor Tim Goodship
| Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy | 2018 |
|
Rachel Challis Dr Edwin Wong Dr Vicky Brocklebank Dr Valerie Wilson Professor Kevin Marchbank et al. | Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease | 2017 |
|
Rachel Challis Dr Edwin Wong Dr Holly Anderson Dr Valerie Wilson Dr Vicky Brocklebank et al. | A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome | 2016 |
|
Dr Valerie Wilson Tom Cox Dr Kate Smith-Jackson Professor David Kavanagh Professor Tim Goodship et al. | Chromosomal rearrangement – a rare cause of complement factor I associated atypical haemolytic uraemic syndrome | 2016 |
|
Dr Valerie Wilson Dr David Bourn Professor Neil Rajan
| CYLD Genetic Testing for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas | 2015 |
|
Dr Valerie Wilson Professor Tim Goodship Dr Veronique Fremaux-Bacchi
| Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome | 2015 |
|
Professor Heather Cordell Dr Valerie Wilson Professor Judith Goodship Professor Tim Goodship
| Factors determining penetrance in familial atypical haemolytic uraemic syndrome | 2014 |
|
Dr Valerie Wilson Dr Rebecca Darlay Dr Katrina Wood Professor Claire Harris Dr Eva-Maria Hunze et al. | Genotype/Phenotype Correlations in Complement Factor H Deficiency Arising From Uniparental Isodisomy | 2013 |
|
Dr Karim Bennaceur Dr Eva-Maria Hunze James Staniforth Dr Lisa Turnbull Dr Valerie Wilson et al. | MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome | 2012 |
|
Dr Valerie Wilson Dr Iain Moore Dr Lisa Turnbull Professor Kevin Marchbank Professor Neil Sheerin et al. | Postpartum aHUS Secondary to a Genetic Abnormality in Factor H Acquired Through Liver Transplantation | 2012 |
|
Dr Mauro Santibanez Koref Dr Valerie Wilson Dr Michael Cunnington Professor John Mathers Dr Ann Curtis et al. | MLH1 Differential Allelic Expression in Mutation Carriers and Controls | 2010 |
|
Dr Valerie Wilson Dr John Hanley Dr Katherine Talks Dr Ann Curtis
| Evaluation of a diagnostic service for haemophilia A incorporating the LightScanner high resolution melt analysis system | 2009 |
|
Dr Uma Nath Dr Valerie Wilson Dr Bridget Wilkins
| FIP1L1-PDGFRA positive chronic eosinophilic leukaemia and associated central nervous system involvement | 2008 |
|
Dr Kate Owen James Eden Dr Claire Jennings Dr Valerie Wilson Professor Timothy Cheetham et al. | Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population | 2006 |
|
Dr Claire Jennings Dr Kate Owen Dr Valerie Wilson Professor Simon Pearce
| A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population | 2005 |
|
Dr Valerie Wilson Dr Mauro Santibanez Koref Dr Lisa Turnbull James Eden Dr Ann Curtis et al. | Altered allele expression in hereditary nonpolyosis colon cancer (HNPCC) patients with nonsense mutations in the Mut L homologue (MLH1) gene. | 2005 |
|
Dr Claire Jennings Dr Kate Owen Dr Valerie Wilson Professor Simon Pearce
| No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease | 2005 |
|
Ravindranath Velaga Dr Claire Jennings Dr Valerie Wilson Dr Kate Owen Professor Simon Pearce et al. | Analysis of the gonadotropin-releasing hormone gene in patients with idiopathic hypogonadotrophic hypogonadism | 2004 |
|
Dr Valerie Wilson
| Childhood mental ability and blood pressure at midlife: Linking the Scottish Mental Survey 1932 and the Midspan studies | 2004 |
|
Dr Valerie Wilson Dr Claire Jennings Dr Kate Owen Dr Peter Donaldson Dr Petros Perros et al. | Role of the CD40 locus in Graves' disease | 2004 |
|
Dr Valerie Wilson Dr Claire Jennings Dr Kate Owen Susan Herington Dr Peter Donaldson et al. | The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease | 2004 |
|
Dr Valerie Wilson
| Population sex differences in IQ at age 11: The Scottish mental survey 1932 | 2003 |
|
Dr Valerie Wilson Dr Alison Howard Professor Dianne Ford Emeritus Professor Barry Hirst
| EGF enhanced transcription of the amino acid transporter hATB(0) in COS-7 cells | 2002 |
|